Spring Bank Pharmaceuticals, Inc. (SBPH)

Trade SBPH now with
2/14/2020 10:12:07 AM Spring Bank Pharma Q4 Net Loss Widens To $7.4 Mln Or $0.45/shr From $5.4 Mln Or $0.37/shr Prior Year
12/26/2019 6:05:26 AM Spring Bank Pharma Stops Dosing, Enrolling Patients In Phase 2b CATALYST Trials
10/17/2019 8:13:50 AM Spring Bank Announces Interim Top-Line Results From First Cohort Of Phase 2 Trial Of Low-Dose Inarigivir Plus Vemlidy
7/29/2019 8:20:12 AM Spring Bank Says FDA Acceptance Of IND For SB 11285 For Advanced Solid Tumors
7/10/2019 4:15:24 PM Spring Bank Pharmaceuticals Elects Pamela Klein To Its Board Of Directors
6/27/2019 8:49:01 AM Spring Bank To Present Pre-clinical Data From STING Antagonist Program
12/18/2018 4:24:44 PM Spring Bank Pharmaceuticals Appoints Scott Smith As Chairman Of Board
11/29/2018 8:08:21 AM Spring Bank Announces Additional Pre-Clinical Data On Its Second-Generation STING Agonist Program
8/8/2018 9:49:39 PM Spring Bank Pharma Announces Pricing Of Underwritten Public Offering Of 3 Mln Shares At $12.50/shr
4/27/2018 8:13:46 AM Spring Bank Pharma Q1 Net Loss $4.9 Mln Or $0.37/Shr Vs $6.5 Mln Or $0.69/Shr Last Year
4/10/2018 8:34:37 AM Spring Bank Announces Expanded Inarigivir Data From ACHIEVE Trial To Be Presented At EASL